S&P 500 Boosts Lululemon; Pfizer Lowers Profits, Revenue Outlook
- October 13th, 2023
- 426 views
Lululemon Athletica Inc. (Nasdaq: LULU), a notable athletic apparel company, will replace Activision Blizzard Inc. (Nasdaq: ATVI) in the S&P 500 index, effective at the opening of trading on Wednesday, October 18.
The S&P 500 is widely recognized as a benchmark for the U.S. stock market, comprising 500 leading companies with significant market capitalization. As a constituent of the S&P 500, Lululemon Athletica will represent its industry among other major sectors.
$LULU was trading at $395.88 in after-hours, up $18.18 (4.81%) following the announcement.
In other news, Pfizer Inc. (NYSE: PFE) is revising its guidance. Solely from its COVID products, the pharmaceutical giant now expects its full-year 2023 revenues to fall between $58.0 billion and $61.0 billion, down from the prior guidance range of $67.0 billion to $70.0 billion. As a result, Pfizer now expects adjusted diluted earnings per share (EPS) to range from $1.45 to $1.65, compared to the initial EPS range of $3.25 to $3.45 for the period
In after-hours, $PFE was trading at $31.03, down $1.08 (-3.36%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Ahead of Earnings: DoorDash, MetLife, and Exelon in the Spotlight
October 27th, 2024A Preview: Stryker, D.R. Horton, and Corning's Earnings in Focus
October 27th, 2024Super Bowl Champion Brings Pro Flag Football to Las Vegas
October 22nd, 2024Aggies Legend Richmond Webb Brings PRO Flag Football To Houston
September 18th, 2024
Member Login